Sema~Glutide
Sema~Glutide
Quantité
Commande minimum de: 1 boxLivraison
Le fournisseur expédiera dans 2–10 jours après confirmation du paiement.
Les marchandises seront expédiées depuis le port de United Kingdom
L'expédition est proposée selon les conditions FOB — le fournisseur couvre les frais jusqu'au port de destination.
Paiement : Western Union
Échantillon disponible · $200.00/échantillon
Euromart Suppliers protection de commande
Chaque paiement que vous effectuez est sécurisé avec un cryptage SSL strict et des protocoles de protection des données PCI DSS
Effectuez des retours locaux gratuits pour les défauts sur les achats éligibles
Réclamez un remboursement si votre commande n'est pas expédiée, est manquante ou arrive avec des problèmes de produit
Meet your supplier
Distributor / Wholesaler • 3 yr • 
UNITED KINGDOM
56%
On-time delivery rate
≤24h
Response Time
75
Employee Size
$500K
Annual Revenue
588
Products Sold
Location
Belfast, United Kingdom
KEY FEATURES
Therapeutic Class: GLP‑1 receptor agonist (peptide therapy)
Primary Uses: Type 2 diabetes management, chronic weight management
Mechanism of Action :
Stimulates insulin secretion when glucose is elevated
Reduces glucagon release
Slows gastric emptying → appetite suppression
Clinical Benefits :
Proven HbA1c reduction
Average 10-15% weight loss during trial
Cardiovascular protection (reduced risk of heart attack/stroke in diabetic patients)
TECHNICAL SPECIFICATIONS
Molecular Type: Synthetic peptide (semaglutide)
Dosage forms :
Injection pens: 0.25 mg, 0.5 mg, 1 mg, 2 mg (weekly dosing)
Oral tablets: 3 mg, 7 mg, 14 mg (daily dosing)
Brands/Models:
Ozempic® – Weekly injection pen for type 2 diabetes
Wegovy® – Weekly injection pen for weight management
Rybelsus® – Daily oral tablet for type 2 diabetes
Storage & Handling :
Injection pens: Refrigerate until first use; room temperature up to 56 days after opening
Tablets: Store at room temperature, away from moisture
Safety profile :
Common side effects: Nausea, diarrhea, constipation
Serious risks: Pancreatitis, gallbladder issues, kidney problems, rare thyroid tumors
Contraindications: Type 1 diabetes, pregnancy, breastfeeding, history of medullary thyroid carcinoma or MEN2
AVAILABLE CONFIGURATIONS
Format and Delivery :
Prefilled injection pens (fixed strengths)
Oral tablets (daily dosing)
Compounded vials (for specialized clinical supply)
Concerntration & Dosing:
Branded pens: fixed strengths (0.25–2 mg)
Oral tablets: fixed strengths (3–14 mg)
Custom compounding: adjustable concentrations for research or clinical customization
Packaging & Lebeling:
Bulk API shipments
Finished product packaging (retail-ready)
Private labeling / white‑label options for distributors
Shipping and Compliance :
Cold chain logistics available
Flexible Incoterms (FOB, CIF, DAP, DDP)
Documentation tailored to HS code classification and regulatory requirements
GB
